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Abstract
Chronic renal fibrosis is the final common pathway of end stage renal disease caused by
glomerular or tubular pathologies. Genetic background has a strong influence on the pro-
gression of chronic renal fibrosis. We recently found that Rowett black hooded rats were
resistant to renal fibrosis. We aimed to investigate the role of sustained inflammation and
oxidative/nitrative stress in renal fibrosis progression using this new model. Our previous
data suggested the involvement of podocytes, thus we investigated renal fibrosis initiated
by doxorubicin-induced (5 mg/kg) podocyte damage. Doxorubicin induced progressive
glomerular sclerosis followed by increasing proteinuria and reduced bodyweight gain in
fibrosis-sensitive, Charles Dawley rats during an 8-week long observation period. In
comparison, the fibrosis-resistant, Rowett black hooded rats had longer survival, milder
proteinuria and reduced tubular damage as assessed by neutrophil gelatinase-associated
lipocalin (NGAL) excretion, reduced loss of the slit diaphragm protein, nephrin, less glomer-
ulosclerosis, tubulointerstitial fibrosis and matrix deposition assessed by periodic acid–
Schiff, Picro-Sirius-red staining and fibronectin immunostaining. Less fibrosis was associ-
ated with reduced profibrotic transforming growth factor-beta, (TGF-β1) connective tissue
growth factor (CTGF), and collagen type I alpha 1 (COL-1a1) mRNA levels. Milder inflam-
mation demonstrated by histology was confirmed by less monocyte chemotactic protein 1
(MCP-1) mRNA. As a consequence of less inflammation, less oxidative and nitrative stress
was obvious by less neutrophil cytosolic factor 1 (p47phox) and NADPH oxidase-2 (p91phox)
mRNA. Reduced oxidative enzyme expression was accompanied by less lipid peroxidation
as demonstrated by 4-hydroxynonenal (HNE) and less protein nitrosylation demonstrated
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by nitrotyrosine (NT) immunohistochemistry and quantified by Western blot. Our results
demonstrate that mediators of fibrosis, inflammation and oxidative/nitrative stress were sup-
pressed in doxorubicin nephropathy in fibrosis-resistant Rowett black hooded rats underly-
ing the importance of these pathomechanisms in the progression of renal fibrosis initiated
by glomerular podocyte damage.
Introduction
Chronic kidney disease (CKD) is a major healthcare problem with a prevalence of 7% in
Europe [1], and over 10% in the US according to the Centers for Disease Control and Preven-
tion [2]. The pathologic manifestation of CKD is renal fibrosis, which is the final common
pathway of many kidney diseases, such as diabetic and hypertensive nephropathy, toxic, ische-
mic or autoimmune renal diseases [3,4].
The clinical presentation of CKD varies widely among patients with the same initial disease
[5]. The severity of symptoms and the rate of CKD progression are influenced by age, gender
[6,7] and numerous pieces of evidence support a role for genetic background in progression
[8,9,10]. We have demonstrated previously that Rowett, black hooded (BH) rats were resistant
to renal fibrosis induced by subtotal nephrectomy plus salt and protein loading [11]. Better
understanding of such resistance can shed light on the pathomechanisms of fibrosis in general
and renal fibrosis specifically.
The anthracycline derivative chemotherapeutic drug, Doxorubicin (Adriamycin, DXR) is
widely used as a rodent model of proteinuric nephropathy leading to renal fibrosis [12].
Although it is generally accepted that an initial injury to podocytes induces proteinuria, the
exact pathomechanism of the DXR-induced nephropathy is poorly understood [13]. The role
of sustained inflammation and oxidative stress has been demonstrated in many experimental
models of renal fibrosis, including the remnant kidney [11,14,15] and DXR nephropathy mod-
els [12,16,17,18,19]. The myocardial and renal side effects of DXR are mainly attributed to the
generation of free oxygen radicals [20]. DXR exerts direct toxic damage to the glomerular
structure leading to loss of nephrin [21] and consequent proteinuria [22]. Proteinuria per se,
sustained inflammation and accompanying oxidative damage are major mechanisms of pro-
gressive renal fibrosis [12]. It has been reported that the DXR-induced oxidative damage in
cells of the renal cortex paralleled renal fibrosis progression [23]. DXR administration to rats
led to severe tubulointerstitial inflammation with marked infiltration by T and B lymphocytes
and macrophages. The intensity of inflammation correlated with the DXR-induced renal dam-
age, and modifying pro-inflammatory pathways affected the severity of renal damage in this
model [24,25,26].
We hypothesized that milder inflammation and milder accompanying oxidative/nitrative
stress may be responsible for the previously published resistance of BH rats to renal fibrosis. To
investigate the role of oxidative/nitrative stress and inflammation in the BH rats’ protection
from renal fibrosis, we compared CD and BH rats in DXR nephropathy model.
Materials and Methods
Ethics Statement
Humane endpoints were used to minimize suffering in survival studies. Animals were
observed and weighed every morning after potentially lethal interventions including DXR
Oxidative Stress in Renal Fibrosis Resistance
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administration. If clinical signs of distress were recognized the animals were euthanized by cer-
vical dislocation performed by a trained personnel. Uremic signs or body weight loss> 40% of
the initial body-weight was an indication for euthanasia. Clinical signs of uremia are described
later. Sacrifice for organ removal was performed under ketamine + xylazin (CP-Ketamin 10%,
CP-Xylazin 2%, CP-Pharma, Burgdorf, Germany) anesthesia. All procedures were performed
in accordance with guidelines set by the National Institutes of Health and the Hungarian law
on animal care and protection. The experimental protocol was reviewed and approved by the
“Institutional Ethical Committee for Animal Care and Use” of Semmelweis University (regis-
tration number: XIV-I-001/2104-4/2012).
Animals and experimental design
Eight-week-old male Charles Dawley (CD) and Rowett, black hooded (BH) rats were used in
the studies (Charles River, Hungary). After arrival the animals were allowed 1 week for accli-
matization. All animals were maintained under standardized (light on 08:00–20:00 h; 40–70%
relative humidity, 22±1°C), specified pathogen-free (SPF) conditions, with free access to water
and standard rodent chow (Altromin standard diet, Germany).
We performed the following three experiments:
1. Renal functional and morphological experiment in DXR-induced acute renal failure;
2. Long term survival study with low dose DXR;
3. Short term survival study with high dose DXR.
In the functional and morphological experiment (exp. 1) rats (n = 8/group) were intrave-
nously injected with 5 mg/kg body weight DXR (Sicor S.r.l. Società Italiana Corticosteroidi,
Italy) dissolved in saline. Equal volume of saline was administered to control animals. DXR
dose was based on literature data and pilot experiments. In the pilot experiments 2 mg/kg DXR
did not induce renal damage, whereas 8 mg/kg DXR caused premature moribund state in some
animals. Urinary protein and NGAL excretion was followed for 8 weeks when the experiment
was terminated and renal morphology was investigated. Long-term survival (exp. 2) was evalu-
ated in age matched BH and CD rats (n = 8/group) (5 mg/kg DXR, iv). For short-term survival
(exp. 3) 10 mg/kg DXR was injected iv (n = 8/group). In survival experiments animals were
euthanized upon signs of uremia, which included reduced locomotion, pilo-erection, body
weight loss or dyspnoea. Blood urea was> 250 mg/dl in each euthanized animal demonstrat-
ing that uremia was the cause of the moribund state.
In order to investigate whether the difference in the degree of tubulointerstitial fibrosis
between the two rat strains was the consequence of different tubular protein load, or BH rats
were resistant to tubulointerstitial fibrosis per se, we formed two sub-groups. In this analysis
CD and BH rats treated with DXR (CD/DXRp, n = 4 and BH/DXRp, n = 5) were matched for
urinary protein excretion and sensitive molecular, inflammatory and fibrosis parameters were
compared.
Proteinuria and NGAL excretion
Proteinuria was measured as a sensitive indicator of podocyte injury and progression of renal
fibrosis. Urine was collected for 24 hours in diuresis cages (Techniplast, Italy) before (self-con-
trol) and biweekly after DXR administration. Urine protein concentration was assessed with a
pyrogallol red colorimetric assay (Diagnosticum Ltd, Budapest, Hungary). Optical density was
measured at 598 nm with the SpectraMax 340 Microplate Spectrophotometer (Molecular
Devices, Sunnyvale, USA).
Oxidative Stress in Renal Fibrosis Resistance
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Urine NGAL levels were measured with rat Lipocalin-2/NGAL DuoSet ELISA Development
kit (R&D Systems, USA) as described by the manufacturer. Optical density was measured with
Victor3 1420 Multilabel Counter (PerkinElmer, WALLAC Oy, Finland) at 450 nm with wave-
length correction set to 544 nm. Concentrations were calculated with WorkOut (Dazdaq Ltd.,
England), using a four parameter logistic curve-fit.
Sacrifice and renal sample collection
In the functional and morphological study (exp. 1), rats were anesthetized with ketamine
+ xylazine 8 weeks after DXR administration. To prevent blood clotting, 1 ml/kg Na-EDTA
(Sigma-Aldrich Corporation, Saint Louis, MO, USA) was injected intraperitoneally. Rats were
bled from the aorto-femoral bifurcation. Animals were perfused through the aorta with 60 ml
cold physiological saline to remove blood from the vasculature. After perfusion, the left kidney
and the heart were removed and sectioned for further analysis. The heart and a third of the left
kidney were fixed in 4% buffered formaldehyde and were later embedded in paraffin for basic
histological and immunohistochemical analysis. The remaining two third of the left kidney
cortex and medulla were separated, frozen in liquid nitrogen and stored at -80°C for molecular
studies.
Renal morphology
Glomerulosclerosis was assessed according to a modified [11,27] scoring system (scores 0–4) of
El Nahas et al. [28] at x400 absolute magnification using an Olympus CX21 microscope
(Olympus Optical Co. Ltd., Japan). Score 0: normal glomerulus. Score 1: thickening of the
basal membrane. 2: mild (<25%), 2.5: severe segmental (>50%) and 3: diffuse hyalinosis. 4:
total tuft obliteration and collapse. The glomerular score of each animal was derived as the
arithmetic mean of 100 glomeruli.
Tubulointerstitial damage was assessed with a semi quantitative scale (magnification ×100)
of percent area affected by tubulointerstitial changes [21,29]. Score 0: normal tubules and inter-
stitium, 1: brush border loss or tubular dilatation in<25% of the field of view (fv). 2: tubular
atrophy, dilation and casts in< 50% fv. Score 3: tubular and interstitial damage in< 75% fv, 4:
tubular atrophy, dilation, casts and fibrosis> 75% fv. The overall score was the mean of 15 fvs.
Inflammatory infiltration was assessed on hematoxylin-eosin stained sections by the percent
of area infiltrated by inflammatory cells (magnification: x400). Score 0: normal glomeruli,
tubules and interstitium, 1: inflammatory cells present in<25% fv. 2: inflammation in< 50%
fv. Score 3: inflammation in< 75% fv, 4: inflammation in> 75% of fv. The overall score was
the mean of 120 fvs.
Collagen deposition in the renal interstitium was demonstrated by Picro-Sirius Red stain-
ing as described previously. Fibrotic areas were quantified using Image J software (National
Institutes of Health, Bethesda, Maryland, US).
Antibodies. For Western blot and immunohistochemistry: 4-hydroxy-2-nonenal (HNE,
mouse monoclonal, clone: HNEJ-2, JaICA, Japan), NT (mouse monoclonal, #189542, Cayman
Chemical Company, Michigan, IL), fibronectin (rabbit polyclonal, Sigma-Aldrich, Budapest,
Hungary), Connexin-43 (1:100, #3512, Cell Signaling, Beverly, MA) were used.
Western Blot. The kidney samples were lysed in RIPA Buffer (Thermo Scientific, Rock-
ford, IL). Protein concentration was determined by the bicinchoninic acid (BCA) protein assay
(Thermo Scientific, Rockford, IL). Twenty μg protein was resolved on 4–12% Criterion XT Bis-
Tris Precast gels (BioRad, Hercules, CA) and transferred to nitrocellulose membrane to detect
HNE or to Polyvinylidene Difluoride (PVDF) membrane to detect NT. The primary NT anti-
body was applied at 1.3 μg/mL and the primary HNE antibody at 0.3 μg/mL. The secondary
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antibody (peroxidase conjugated goat anti-mouse, PerkinElmer, Santa Clara, CA) was applied
at 0.25 μg/mL. Blots were incubated in enhanced chemiluminescence substrate, Supersignal
West Pico Chemiluminescent Substrate (Thermo Scientific, Rockford, IL), and were exposed
to photographic film. After stripping membrane with Restore Western Blot Stripping Buffer
(Thermo Scientific, Rockford, IL), as a loading control, peroxidase conjugated anti-actin (AC-
15 Abcam, Cambridge, MA) was applied at 70 ng/mL concentration in blocking buffer for 1 h
at room temperature.
Immunohistochemistry. Paraffin sections on Superfrost Ultra Plus Adhesion Slides
(Thermo Fisher Scientific Inc, Waltham, MA, USA) were deparaffinized and rehydrated in eth-
anol. Fibronectin immunohistochemistry was performed with rabbit polyclonal anti-fibronec-
tin antibody (1:2000, Sigma-Aldrich, Budapest, Hungary), using the avidin–biotin method
[30]. HNE and NT immunohistochemistry was performed with mouse monoclonal antibody
(HNE clone: HNEJ-2, JaICA, Japan; NT clone: #189542, Cayman Chemical Company, Michi-
gan, IL). Color development was induced by incubation with diaminobenzidine (DAB) kit
(Vector Laboratories, Burlingame, CA). Pictures were taken from the stained sections for fur-
ther analysis. The fibronectin stained area was quantified with Image J software.
Heart fibrosis markers
In a separate group, the hearts were removed and fixed in 4% buffered formalin and embedded
similarly to the renal samples 8 weeks after 5 mg/kg DXR administration. Consecutive sections
were stained with Masson’s trichrome to detect collagen deposition as a sign of chronic fibrosis,
and direct immunofluorescence was performed for connexin-43 (Cx43), an early marker of
cardiomyocyte damage.
Monitoring mRNA levels with Real-Time quantitative Polymerase Chain
Reaction (RT-qPCR)
RNA preparation. Total RNA for RT-qPCR was extracted by homogenizing 50–80 mg
pieces of renal cortex in TRI Reagent (Molecular Research Center Inc., Cat. NO.: TR118)
according to the manufacturer’s protocol. DNA contamination was removed by TURBO
DNase (Life technologies, Ambion, Cat. No: AM2238). RNA concentration and purity of the
samples was measured with the NanoDrop 2000c Spectrophotometer (Thermo Fisher Scien-
tific Inc, Waltham, MA, USA). The RNA integrity was verified by electrophoretic separation
on 1% agarose gel.
RT-qPCR analysis of renal mRNA levels. Reverse transcription of 1 μg total renal RNA
into cDNA was carried out using random hexamer primers and the High-Capacity cDNA
Archive Kit (Applied Biosystem, USA) according to the manufacturer’s protocol. Messenger
RNA levels of NADPH oxidase-2 (NOX-2, p91phox, cytochrome b-245 beta polypeptide), neu-
trophil cytosolic factor 1 (Ncf1, p47phox), collagen type I, alpha 1 (COL1A1), transforming
growth factor β1 (TGF-β1), connective tissue growth factor (CTGF) and macrophage chemo-
tactic protein 1, (MCP-1, chemokine (C-C motif) ligand 2, Ccl2) were measured by RT-qPCR
(Qiagen, Hilden, Germany) and target mRNA levels were normalized to actin mRNA levels
(Table 1).
Nephrin mRNA levels were measured by double-stranded DNA (dsDNA) dye based RT-qPCR
withMaxima SYBR Green RT-qPCRMaster Mix (Thermo Fisher Scientific Inc., Waltham, MA,
USA), and the mRNA values were normalized to glyceraldehyde-3-phosphate dehydrogenase.
Mean values are expressed as fold mRNA levels relative to the control using the formula 2-Δ(ΔCt)
(Ct: cycle time, ΔCT = CTtarget−CTnormalizer and Δ(ΔCT) = ΔCT stimulated- ΔCTcontrol) [31].
Oxidative Stress in Renal Fibrosis Resistance
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Statistics
Two-way ANOVA with or without repeated measures were used for multiple comparisons.
Post hoc analyses were done with Holm-Sidak‘s test. Logarithmic transformation of data was
used if Bartlett’s test indicated a significant inhomogeneity of variances. Variables of the two
sub-groups within the BH/DXR and the CD/DXR groups were compared using unpaired t-
test. Survival was analyzed according to the Kaplan-Meier method. The null hypothesis was
rejected if p< 0.05. Data were expressed as means ±SEM if not specified otherwise. All statisti-
cal analysis was done with GraphPad Prism (version 6.01, GraphPad Software Inc, San Diego,
CA, USA).
Results
Heart toxicity was absent 8 weeks after 5 mg/kg DXR
Histology of the heart did not show necrosis or other morphological alterations of cardiomyo-
cytes. Massons’s trichrom staining was devoid of collagen deposition, and connexin-43 immu-
nostaining did not demonstrate any sign of cardiomyocyte damage. Thus, a single dose of 5
mg/kg DXR did not induce any detectable chronic heart damage (data not shown).
CD rats became moribund earlier than BH rats at both low and high
doses of DXR
BH rats became moribund significantly later following the 5 mg/kg DXR dose, compared to
CD rats (Fig 1A). The first CD rat became moribund 75 days after DXR administration, and
there were no survivors after day 90 from this strain. The first BH became moribund 86 days
after DXR, and there were survivors even 159 days after DXR administration. The median sur-
vival after DXR was 85.5 days for the CD rats, while it was 100 days for the BH rats (p<0.05).
A higher dose of 10 mg/kg DXR led to a more severe outcome. The median survival of CD
rats was 10 days compared to 15 days of the BH rats (Fig 1B). DXR administration caused less
severe kidney damage than subtotal nephrectomy (SNX) and salt + protein loading in our pre-
vious study [11] as demonstrated by longer survival.
DXR inhibited bodyweight gain more in CD than in BH rats
DXR-administration inhibited weight gain in BH and CD rats (Fig 2A). BH rats had a slower
growth rate than age matched CD rats. Bodyweight constantly increased in all control animals.
Body weight gain was significantly inhibited in DXR-injected CD rats (CD/DXR) already start-
ing at week 4 while CD/DXR rats started to lose weight by week 8. On the contrary, significant
weight gain inhibition was observed in BH rats (BH/DXR) only at week 8.
Table 1. Qiagen primer reference numbers.
Gene Reference sequence Qiagen primer reference number
p91phox (NOX2) NM_023965.1 QT00195300
p47phox (Ncf1) NM_053734 QT00189728
MCP-1 (Ccl2) NM_031530.1 QT00183253
TGF-β1 NM_021578.2 QT00187796
CTGF NM_022266.2 QT00182021
COL1A1 NM_053304.1 QT02285619
doi:10.1371/journal.pone.0127090.t001
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Proteinuria was milder in BH than CD rats after DXR
Proteinuria was assessed as a marker of podocyte damage and progression of renal fibrosis. In
the functional and morphological experiment (exp. 1) 5 mg/kg DXR induced progressive pro-
teinuria commencing 2 weeks after DXR in CD rats (Fig 2B). Proteinuria started later and pro-
gressed slower in BH than in CD rats, and proteinuria was significantly milder at each time-
point in BH/DXR than in CD/DXR rats.
Urinary NGAL excretion—a known marker of tubular epithelial damage—increased in
both DXR-injected groups after the fourth week. Similarly to proteinuria, NGAL excretion was
significantly milder in the BH/DXR than in the CD/DXR group (Fig 2C).
Fig 1. Survival (long term: A, short term: B). CD: CD rats, BH: BH rats. DXR: Doxorubicin injected rats (5
mg/kg).
doi:10.1371/journal.pone.0127090.g001
Fig 2. Body weight changes (A) proteinuria (B) and urinary NGAL excretion (C). CD: CD rats, BH: BH
rats. c: saline-injected, DXR: Doxorubicin-injected rats (5 mg/kg). *: p<0.05 vs. strain-identical, negative
control group, †: p<0.05 vs. CD/DXR, positive control group.
doi:10.1371/journal.pone.0127090.g002
Oxidative Stress in Renal Fibrosis Resistance
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Renal histological damage and inflammation were more severe in CD
than in BH rats 8 weeks after DXR
Both CD and BH rats injected with saline had normal kidneys with no or minimal glomerular
and tubular abnormalities 8 weeks after the injection. DXR administration caused glomerular
damage in all age-matched rats. However, BH/DXR rats had milder glomerular and tubular
damage compared to CD/DXR rats (Fig 3A–3F, Table 2). Glomerular and tubular damage
were distributed unevenly in rats, similarly to human focal segmental glomerulosclerosis
(FSGS) [18]. In parallel with milder proteinuria and urinary excretion of NGAL in BH rats,
intact glomeruli (Score: 0) were significantly more common in DXR-injected BH than in CD
rats (Table 2). However, mild (Score: 0.5–1.5) (CD: 50.7 vs. BH: 28.4%) and severe (Score 2)
(CD: 13.3 vs. BH: 3.3%) glomerular damage was significantly more common in CD/DXR vs.
BH/DXR rats. Probably as a consequence of different degrees of glomerular damage, tubuloin-
terstitial damage was milder in BH than in CD rats (Table 2).
Eight weeks after DXR administration severe inflammatory infiltration by neutrophil granu-
locytes, lymphocytes and macrophages was evident in the kidney samples of DXR-injected CD
Fig 3. Renal histopathology. Top row (periodic acid–Schiff (PAS) staining) (A-C): Glomerular damage in
the affected areas. Middle row PAS staining) (D-F): Tubular damage in the affected areas. Lower row
(hematoxylin-eosin (HE) staining) (G-I): Tubulointerstitial inflammatory infiltration. Saline-injected control rats
(A,D,G); CD-DXR: doxorubicin-injected (5 mg/kg) CD rats (B,E,H); BH-DXR: doxorubicin-injected BH rats (C,
F,I). J: Sirius red staining (100x). L: Fibronectin immunohistochemistry (400x).K, M: computerized
quantification of the immunostained areas. CD: CD rats, BH: BH rats. c: saline-injected, DXR: Doxorubicin-
injected rats (5 mg/kg). *: p<0.05 vs. strain-identical, control group, †: p<0.05 vs. CD/DXR, control group.
doi:10.1371/journal.pone.0127090.g003
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rats. In parallel with less proteinuria and morphological damage, inflammation was signifi-
cantly milder in BH/DXR rats than in CD rats (Fig 3G–3I).
Milder fibrosis was associated with less oxidative stress and
inflammation
Fibrosis was strikingly more intense in CD/DXR than in BH/DXR rats as demonstrated by Sir-
ius red staining (Fig 3J and 3K). Fibronectin immunostaining was detected only in 5.2±0.6% of
the scanned areas in the saline-injected control groups, but increased significantly in the DXR-
injected CD group. Significantly less fibronectin staining was detected in BH/DXR than in CD/
DXR rats (Fig 3L and 3M).
TGF-β1 and CTGF mRNA levels in the kidney cortex were not significantly different in
the control groups compared to DXR-injected BH rats, but were significantly elevated in the
CD/DXR group (Fig 4A and 4B). COL1A1 mRNA levels were elevated in DXR-injected rats,
but the elevation was significantly higher in the CD/DXR group than in the BH/DXR group
(Fig 4C).
Nephrin is an important component of the podocyte foot processes forming the slit dia-
phragm. It plays an important role in the maintenance of the structural integrity and the func-
tional soundness of the slit diaphragm [32]. Nephrin mRNA levels decreased in the kidney
cortex of the CD/DXR group, but it was not reduced in the BH/DXR group (Fig 4D) support-
ing further a milder glomerular damage in BH/DXR rats.
The mRNA levels of pro-inflammatory monocyte chemotactic protein 1 (MCP-1)
(Fig 4E) and pro-oxidant markers: p91phox and p47phox (Fig 4F and 4G) increased in both
DXR-injected groups; however the elevation was milder in the BH/DXR group.
4-hydroxy-2-nonenal and nitrotyrosine. In the background of more severe kidney func-
tion deterioration demonstrated by proteinuria and fibrosis markers, severe lipid peroxidation
and nitrative stress were detected in the kidneys of DXR-injected CD rats, while very mild
changes were seen in the HNE or NT stained paraffin sections from the BH/DXR rats. Less
staining was corroborated by Western blot demonstrating significantly more HNE and NT in
CD than in BH rats 8 weeks after DXR administration (Fig 5).
Tubulointerstitial fibrosis and inflammation were milder in DXR-treated
BH vs. CD rats despite similar proteinuria
Urinary protein excretion and renal nephrin mRNA levels were similar in the two subgroups
of CD and BH rats (BH/DXRp, CD/DXRp) with similar proteinuria (Table 3). Markers of
fibrosis such as sirius red staining and relative renal expression of TGF-β1, CTGF, COL1A1
were significantly lower in BH/DXRp vs. CD/DXRp rats. Paralleling less fibrosis, tubular dam-
age detected by urinary NGAL excretion, markers of oxidative damage such as p47phox and
Table 2. Renal morphology.
Groups Undamaged glomeruli (%) Glomerulosclerosisscore Tubular score Inflammation score
CD/DXR 36.3±13.4 0.79±0.22 2.01±0.64 1.61±0.32
BH/DXR 68.3±8.4 0.32±0.11 0.86±0.44 1.06±0.20
Control 93.3±4.4 0.06±0.04 0.00±0.00 0.18±0.06
P value(CD/DXR vs. BH/DXR) <0.001 <0.001 <0.001 <0.01
CD: CD rats, BH: BH rats. Control: saline-injected, DXR: Doxorubicin-injected rats (5 mg/kg). Mean±SD, n = 10/group.
doi:10.1371/journal.pone.0127090.t002
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p91phox expression and inflammation (MCP-1 expression) were significantly lower in BH/
DXRp than CD/DXRp rats (Table 3). All raw data are available in S1 Data Supplement.
Discussion
Renal fibrosis is an intractable medical condition with high mortality and low quality of life.
We present here an animal model useful to investigate the pathomechanisms of hereditary sus-
ceptibility or resistance to renal fibrosis in various kidney injury models [10,33,34]. We demon-
strated recently that BH rats were resistant to renal fibrosis with better preserved renal
function and glomerular structure in a clinically relevant model of subtotal nephrectomy com-
bined with salt and protein loading [11]. In the present study we demonstrate that less oxida-
tive/nitrative stress and inflammation was associated with slower progression of fibrosis in the
resistant strain. Taken together with our previous report demonstrating similar resistance of
BH vs. CD rats in the subtotal nephrectomy model, our present findings underline the patho-
physiological relevance of inflammation and oxidative/nitrative stress pathways in fibrosis
progression.
Fig 4. Renal cortical mRNA levels of fibrosis related, inflammatory and oxidativemarkers. (A: TGF-β1,
B:CTGF, C: COL1A1, D: nephrin, E:MCP-1 F: p47phox,G: p91phox. CD: CD rats, BH: BH rats. c: saline-
injected, DXR: Doxorubicin-injected rats (5 mg/kg). TGF-β1: transforming growth factor β1; CTGF:
connective tissue growth factor; COL1A1: collagen type I alpha 1; MCP-1: monocyte chemotactic protein 1;
p47phox: neutrophil cytosolic factor 1; p91phox: cytochrome b-245, beta polypeptide; *: p<0.05 vs. strain-
identical control group, †: p<0.05 vs. CD/DXR.
doi:10.1371/journal.pone.0127090.g004
Oxidative Stress in Renal Fibrosis Resistance
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DXR nephropathy in rodents is a widely used experimental model of human FSGS [12,35].
Direct exposure of the kidneys to DXR is a requirement for the development of podocyte injury
in rats, as clipping the renal artery during DXR injection prevents nephropathy [35]. A single
intravenous injection with 4–7,5 mg/kg DXR led to well predictable deterioration of glomerular
structure, proteinuria, tubular and interstitial inflammation culminating in renal fibrosis in
fibrosis-sensitive Sprague Dawley or Wistar rats [36]. Glomerular structural changes develop
in a well predictable manner: altered mRNA levels of nephrin, podocyn and NEPH1, and swell-
ing of the foot-processes are present at day 7 [37]. Podocyte swelling with cytoplasmic vesicles
appear at day 14, and finally widespread podocyte foot process fusion at day 28 [38]. As a
marker of glomerular filtration barrier damage, proteinuria develops [39]. Repeated low dose
DXR has been widely used to induce toxic cardiomyopathy. In our model cardiac toxicity was
absent after a single DXR injection, as demonstrated by histology or the sensitive cardiomyopa-
thy marker Cx-43.
Fig 5. Oxidative/nitrative stressmarkers. A: 4-hydroxy-2-nonenal (HNE) immunohistology (400x) andB:
quantification byWestern blot.C: Nitrotyrosine (NT) immunohistology (400x) andD: quantification by
Western blot. CD: CD rats, BH: BH rats. c: saline-injected, DXR: Doxorubicin-injected rats (5 mg/kg).
doi:10.1371/journal.pone.0127090.g005
Table 3. Comparison of doxorubicin-injected (DXR) Rowett, black hooded (BH) and Charles Dawley
(CD) rats with similar proteinuria (BH/DXRp and CD/DXRp subgroups).
CD/DXRp (n = 4) BH/DXRp (n = 5) P value
U Protein, week 8 (mg/24h) 396.5±82.2 362.5±30.3 0.42
Nephrin 0.68±0.16 0.87±0.19 0.19
U NGAL, week 8 (mg/24h) 10.1±2.0 5.2±1.6 <0.01
Sirius red (%) 18.0±1.6 11.8±1.0 <0.01
Fibronectin (%) 7.91±2.45 5.55±1.19 0.16
TGF-β1 6.00±2.36 2.13±1.23 <0.05
CTGF 3.71±2.10 0.54±0.11 <0.05
COL1A1 23.09±6.14 5.79±2.41 <0.01
p47phox 4.69±1.51 1.95±0.36 <0.05
p91phox 10.69±2.47 1.94±0.78 <0.01
MCP-1 9.23 3.28 3.46±0.99 <0.05
doi:10.1371/journal.pone.0127090.t003
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BH rats have a slower growth rate than age matched CD rats under healthy circumstances.
The body weight curve in control animals of our study were similar to the previous findings
[40,41].
In our study, sensitive CD rats developed significant and progressive proteinuria starting
two weeks after 5 mg/kg DXR similarly to that shown in previous publications [37–42].
Nephrin plays an important role in maintaining the structural integrity and the functional
soundness of the slit diaphragm [32]. In the background of the proteinuria significant nephrin
loss was demonstrated in CD rats. The severity of proteinuria was milder and progression was
slower in BH rats. Thus, as BH rats had similar nephrin mRNA levels to the strain-identical
controls, nephrin might play a central role in the progression of DXR-induced fibrosis. Protein-
uria-associated interstitial fibrosis and tubular atrophy (IFTA) has been recognized previously
[43]. Podocyte dysfunction and consequent proteinuria has been recently reinforced as a major
determinant of tubular injury, inflammation and apoptosis leading to progressive IFTA [44].
According to our present study and previous literature [45] IFTA developed as part of DXR
nephropathy. Urinary NGAL excretion is a sensitive marker of tubular damage not only during
acute kidney injury [[46, 47],] but also during IFTA [48]. In our study, significantly less pro-
teinuria was accompanied by reduced tubular damage and less urinary NGAL excretion after
DXR in the BH than in the CD strain. Similarly, less renal damage and less proteinuria was
accompanied by better maintained body weight and significantly prolonged survival in BH
rats. These data support that IFTA is secondary to proteinuria in the DXR model. The single
administration of DXR and consequent albuminuria led to tubulointerstitial inflammation and
fibrosis demonstrated by PAS, Sirius red and fibronectin and collagen synthesis and the pres-
ence of the pro-fibrotic transforming growth factor (TGF-β1) [[49, 50],] and its downstream
mediator connective tissue growth factor (CTGF) [51]. Significant reduction of these fibrotic
pathways in the resistant BH strain underlines the relevance of the TGF-β1-CTGF cascade-
mediated matrix deposition in the development of DXR-induced renal fibrosis (Fig 6).
Oxidative and nitrative stress has been proposed as the mechanism by which DXR induces
glomerular toxicity in rats. Redox cycling of the quinone functional group of DXR was pro-
posed as the key factor in DXR nephrotoxicity [52]. Reactive oxygen species (ROS) may initiate
a degenerative cascade by the oxidation of cellular thiols and lipid membrane structures [53].
DXR has been suggested to upregulate NADPH-oxidase (NOX), an important source of ROS
in the kidney [54]. However, the role of oxidative mechanisms in DXR toxicity has been ques-
tioned as well [55]. In our study, signs of lipid peroxidation and nitrative stress were milder in
the BH rats, compared to the CD rats suggesting that less oxidative and nitrative stress may be
responsible, at least in part, for the resistance of BH rats against renal fibrosis. This observation
supports the role of oxidative and nitrative mechanisms in DXR toxicity.
Our results obtained in the subgroups of DXR-treated CD and BH rats with similar urinary
protein excretion support our view that BH rats are less susceptible to tubulointerstital fibrosis
induced by proteinuria. Renal nephrin mRNA expression was similar in the two subgroups,
suggesting that the degree of podocyte injury and slit diaphragm leakiness is a primary deter-
minant of proteinuria independent of the genetic background. However, despite similar pro-
teinuria, most markers of renal fibrosis, oxidative stress and inflammation were significantly
lower in BH rats. These results support the role of inflammation in proteinuria-induced tubu-
lointerstitial fibrosis.
Resistance mechanisms against DXR nephropathy were studied previously in rat [56] and
mouse [57] strains. In spontaneously hypertensive (SHR) rats, cardio- and nephrotoxicity of
DXR was more severe than in congenic Wistar-Kyoto (WKY) and in SHR-heart failure rats
after subsequent administration of 2 mg/kg DXR on 8 consecutive days. Twelve weeks after the
last dose of DXR renal lesions were similar to those in our study with podocyte adhesion
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leading to glomerulosclerosis and mononuclear infiltration, tubular atrophy and fibrotic matrix
expansion in the tubulointerstitium [56]. Severity of these histological changes correlated with
strain sensitivity. Similarly to our study, strain differences were partially explained by a differ-
ence in the severity of inflammation and arachidonic acid metabolism.
Sensitivity to DXR nephropathy was investigated previously in fibrosis-resistant C57BL/6
and-sensitive BALB/c mice [10]. The difference in susceptibility was attributed to a mutation
in the PRKDC gene encoding the catalytic subunit of a DNA activated protein kinase
(DNA-PK), a double stranded break repair protein [[10, 58]]. This mutation is also responsible
for the severe combined immunodeficiency (SCID) phenotype in mice and rats [59]. DNA-PK
expression and activity was also profoundly lower in BALB/c than C57BL/6 mice in a radiation
induced apoptosis model [60]. Thus, DNA-PK seems to be crucial in toxic injury models. As
inflammation and related oxidative stress also induces DNA damage, the PRKDC gene may
play an important role also in our model.
Fibrosis is mediated by myofibroblasts activated by TGF-β1, MCP-1, etc. [61]. In our study,
decreased MCP-1 mRNA levels were found in resistant BH rats, which is one of the key chemo-
kines for the migration and infiltration of macrophages to sites of inflammation [62]. The
mRNA levels of p91phox, also known as NADPH oxidase 2 (NOX2) were also lower in BH rats.
NOX2 plays an important role in ROS production of phagocytes and T cells. Furthermore, the
mRNA level of p47phox, which plays a role in the activation of the NOX2/p22phox complex in
the membrane of phagocytes [63], was also milder in BH rats. These findings suggest that less
inflammation, accompanied by milder ROS production of the neutrophil cells and macro-
phages may play a role in the resistance of BH rats against DXR nephropathy.
Fig 6. Suggested mechanisms of doxorubicin induced nephropathy. A single administration of
doxorubicin induced podocyte damage demonstrated by loss of nephrin and leading to proteinuria.
Proteinuria damages tubules as demonstrated by increased urinary NGAL excretion. Tubular damage leads
to interstitial inflammation and fibrosis with collagen and fibronectin deposition. Inflammation is accompanied
by oxidative/nitrative damage triggering further immune activation. Reverse arrows symbolize main elements
of the vicious circle. Sustained injury activates the TGF-β1 and CTGF profibrotic axis. Sustained injury
eventually leads to fibrotic end-stage kidney. NGAL: neutrophil gelatinase-associated lipocalin; TGF-β1:
transforming growth factor β1; CTGF: connective tissue growth factor.
doi:10.1371/journal.pone.0127090.g006
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Conclusions
In conclusion, resistance of BH rats against renal fibrosis highlighted the role of inflammation-
induced oxidative/nitrative stress in chronic podocyte injury leading to glomerulosclerosis and
consequent proteinuria in DXR nephropathy. Tubulointerstitial fibrosis is most likely second-
ary to proteinuria in this model.
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